Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sanjie Zhentong is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of endometriosis, adenomyosis, and associated pelvic pain or dysmenorrhea. It is typically administered as a capsule. The formulation is composed of several herbal ingredients, including *Sanguis Draconis* (Dragon's Blood), *Radix et Rhizoma Rhei* (Rhubarb), *Myrrha* (Myrrh), and *Olibanum* (Frankincense). Its mechanism of action in TCM terms involves softening hardness to dissipate nodules (Sanjie) and relieving pain (Zhentong) by promoting blood circulation and removing blood stasis. In clinical practice, it is often used as an adjuvant therapy following surgery or in combination with hormonal treatments like GnRH agonists to prevent recurrence and manage symptoms of endometriosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sanjie zhentong.